With GUARDUS, ZEISS Acquires a Software Supplier for Analysis and Management in Production

OBERKOCHEN/Germany, ULM/Germany, 2018-04-24. ZEISS and GUARDUS have announced that the software solutions supplier for computer-supported quality assurance and production management systems based in the German city of Ulm has become a wholly owned subsidiary of the ZEISS Group. For ZEISS, the integration of GUARDUS into its Industrial Metrology (IMT) business group will further strengthen its... Read more

Twist Bioscience Accelerates Global Expansion with Strategic Asia Pacific Distribution Agreements

Download PDF SAN FRANCISCO, Calif.  – April 18, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the... Read more

Brüel & Kjær Sound & Vibration and HBM to Merge

18 April 2018 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Brüel & Kjær Sound & Vibration (‘BKSV’) and HBM will be merging their activities from 1 January 2019. Both BKSV and HBM are operating companies within the Test and Measurement segment of Spectris. The new company will be... Read more

Bruker Acquires nanoIR Company Anasys Instruments

Infrared Spectroscopy Technology Adds to Bruker’s NanoScale Measurement Portfolio BILLERICA, Mass., April 17, 2018 /PRNewswire/ — Bruker today announced that it has acquired Anasys Instruments Corp., a privately held company that develops and manufactures nanoscale infrared spectroscopy and thermal measurement instruments. This acquisition adds to Bruker’s portfolio of Raman and FTIR spectrometers, as well as... Read more

Labcyte Reaches Agreement With Merck to Supply Acoustic-Mass Spectrometry Equipment

April 17, 2018 04:30 AM Pacific Daylight Time SAN JOSE, Calif.–(BUSINESS WIRE)–Labcyte Inc. announced today that the company has entered an agreement with Merck, known as MSD outside the United States and Canada, to utilize Acoustic-Mass Spectrometry (Acoustic-MS) in drug discovery and development. Pioneered by Labcyte, acoustic droplet ejection (ADE) technology uses the gentle energy... Read more

Pall Corporation and Artesyn Biosolutions Announce Collaboration Agreement to Industrialize Single-Use Technology

PORT WASHINGTON, N.Y., April 16, 2018 /PRNewswire/ — Pall Corporation, a global leader in filtration, separation and purification, announced a strategic collaboration between its Biotech business unit and Artesyn Biosolutions, a leading innovator in single-use components and fluid management technologies. The agreement will encompass a co-development partnership, delivering complete solutions from clinical to commercial-scale for single-use automated bioprocessing... Read more

Sartorius Stedim Biotech and Penn State University announce partnership

University Park, Pennsylvania, USA | Goettingen, Germany, April 16, 2018 – Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to... Read more

Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb’s oncology portfolio. The companies plan to develop a diagnostic version of the Illumina TruSight Oncology... Read more

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

— Scientists require human biofluid, tissue and cell specimens that meet precise requirements to advance biomedical research, but often have difficulty locating the specific patient samples they need. — iSpecimen works with laboratories to compliantly aggregate for researchers remnant human samples that would otherwise be discarded. — Using the CentraLink Data Management System and Aptio... Read more